RecruitingNCT00923507

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

Studying Splenic marginal zone lymphoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Adrian U Wiestner, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment: 1000 target
Eligibility: 18-110 years · All sexes
Timeline: 2008

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00923507 on ClinicalTrials.gov

← Back to all trials